Employment of inositol in the complex treatment of patients with polycystic ovary syndrome
Vol 82 No 1 (2019), Gynecology
Vol 82 No 1 (2019)

Employment of inositol in the complex treatment of patients with polycystic ovary syndrome

Gynecology
https://doi.org/10.35339/ekm.2019.01.14
Published August 18, 2020
I.A. Kachaylo
Kharkov National Medical University
https://orcid.org/0000-0002-9892-4353
I.A. Guz
Kharkov National Medical University
https://orcid.org/0000-0002-6785-4903
О.А. Olkhovskaya
KNP Kharkiv Regional Council "Regional Center for Family Planning and Human Reproduction"
https://orcid.org/0000-0003-3602-3055
U.Yu. Moroz
Kharkov National Medical University
https://orcid.org/0000-0002-4302-178X
K.L. Moroz
KNP "City Clinical Hospital № 18" of the Kharkiv City Council
https://orcid.org/0000-0003-3565-4058
PDF (Українська)

Keywords

polycystic ovary syndrome
inositol
treatment

How to Cite

Kachaylo, I., Guz, I., OlkhovskayaО., Moroz, U., & Moroz, K. (2020). Employment of inositol in the complex treatment of patients with polycystic ovary syndrome. Experimental and Clinical Medicine, 82(1), 94-98. https://doi.org/10.35339/ekm.2019.01.14
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

The article is devoted to the modern method of treatment of polycystic ovary syndrome (PCOS) with the application of inositol. It is shown that the use of inositol in PCOS normalizes not only metabolic and hormonal parameters, but also helps restore menstrual function, improve ovarian function, as well as hypothalamic-hypophysial function and beginnings of pregnancy
https://doi.org/10.35339/ekm.2019.01.14
PDF (Українська)

References

Vihlyaeva E.M. (Eds). (2000). Rukovodstvo po endokrinnoy ginekologii [Guide to Endocrine Gynecology]. Мoscow: Meditsinskoe informatsionnoe agenstvo, 768 p. [in Russian].

Mihalevich S. I. (2002). Preodolenie besplodiya. Diagnostika, klinika, lechenie [Overcoming infertility. Diagnosis, clinic, treatment]. Minsk: Belaruskaya navuka, 191 p. [in Russian].

Dzhenatstsani A.D., Lantsoni S., Rikkeri F., Yasonni V.M. (2008). Vvedenie mio-inozitola polozhitelno vliyaet na giperinsulinemiyu i gormonalnyie parametryi u patsientok s izbyitochnyim vesom s sindromom polikistoznyih yaichnikov [Introduction of myo-inositol has a positive effect on hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome]. Ginekologicheskaya endokrinologIya – Gynecological endocrinology, vol. 24, № 3, pp. 139–146 [in Russian].

Morgante Dzh., Orvieto R., Di Sabatino A., Musakko M., De Leo V. (2011). Rol dobavok inozitola u patsientok s sindromom polikistoznyih yaichnikov s insulinorezistentnostyu, podvergayuschimsya induktsii ovulyatsii v nizkih dozah gonadotropina [The role of inositol supplementation in patients with polycystic ovary syndrome with insulin resistance undergoing induction of ovulation in low doses of gonadotropin]. Fertilnost i besplodie – Fertility and infertility, vol. 95, № 8, pp. 2642–2654 [in Russian].

Karlomano Dzh., Unfer V. (2011). Bezopasnost inozitola: klinicheskie dokazatelstva [Safety of inositol: clinical evidence]. Evropeyskiy obzor maditsinskih i farmakologicheskih issledovaniy – European review of madicine and pharmacological research, vol. 15, № 8, pp. 931–941[in Russian].

Strugari A. M., Botnari Dzh., Agoray L., Grigoriu I. C., Butnari E. (2013). Osobennosti i kurs laktatsidoza kak sledstvie lecheniya metforminom [Features and course of lactic acidosis as a result of treatment with metformin]. Revista Medico-Chirurgicala a Societatii de Medici si Naturalisti din Iasi, vol. 117, № 4, pp. 1035–1042 [in Russian].

Konstantinov D., Minotstsi Dzh., Minotstsi F., Garaldi C. (2009). Metabolicheskie i gormonalnyie effektyi priema inozitola u zhenschin s sindromom polikistoznyih yaichnikov: dvoynoe slepoe issledovanie [The metabolic and hormonal effects of inositol in women with polycystic ovary syndrome: a double-blind study]. Evropeyskiy obzor meditsinskih i farmakologicheskih issledovaniy – European review of medical and pharmacological studies, vol. 13, № 2, pp. 105–112 [in Russian].